Australia Blood Ketone Meter Market is Segmented By Product Type (Only Blood Ketone Monitoring, Blood Glucose and Ketone Monitoring, Consumables), By Application (Human, Veterinary), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Home Care Settings, Veterinary Hospitals and Clinics, Others). The report offers the value (in USD million) for the above mentioned segments.
Market Size in USD
CAGR7%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 7% |
Market Concentration | Medium |
Major Players | Abbott, ACON Laboratories Inc., Nipro Corporation, EKF Diagnostics Holdings Plc., Nova Biomedical |
The Australia Blood Ketone Meter Market is estimated to be valued at USD 10.9 Mn in 2024 and is expected to reach USD 18.8 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7% from 2024 to 2031.
Factors such as increasing prevalence of diabetes, growing obese and geriatric population, rising awareness regarding diabetes self-management and technological advancements in blood ketone meters are expected to drive the market growth.